Inventor · disambiguated record
Yvan Fischer
Also filed as: FISCHER YVAN
8 granted patents·7 pending applications·17 citations·filing 2003–2010
80Inventor score
Top patents by PatentIndex Score
15 records- 0180US7368582B2Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2004·Granted May 6, 2008·11 cites·11 claims
- 0274US7410962B2Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2007·Granted Aug 12, 2008·2 cites·11 claims
- 0373US7427611B2Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2006·Granted Sep 23, 2008·2 cites·11 claims
- 0471US7262184B2Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2004·Granted Aug 28, 2007·2 cites·14 claims
- 0562US7534903B2Use of amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl-compounds in the treatment of cardiac arrhythmia and other disease statesSOLVAY PHARM GMBH·Filed 2008·Granted May 19, 2009·0 cites·17 claims
- 0658US8273905B2Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivativesMOLONEY BRIAN·Filed 2009·Granted Sep 25, 2012·0 cites·13 claims
- 0757US7714150B2Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivativesSOLVAY PHARM GMBH·Filed 2006·Granted May 11, 2010·0 cites·11 claims
- 0853US7452875B2Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2007·Granted Nov 18, 2008·0 cites·11 claims
- 0946US2005288272A1Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonistsSOLVAY PHARM GMBH·Filed 2005·Application pending·0 cites
- 1046US2006205625A1Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diureticsSOLVAY PHARM GMBH·Filed 2006·Application pending·0 cites
- 1143US2004162345A1Compounds with NEP/MP-inhibitory activity and uses thereofSOLVAY PHARM GMBH·Filed 2003·Application pending·0 cites
- 1242US2008045551A1Pharmaceutical combination comprising an adenosine a1 antagonist and a radiocontrast mediaHOCHER BERTHOLD·Filed 2007·Application pending·0 cites
- 1342US2008027082A1Use of adenosine a1 antagonists in radiocontrast media induced nephropathyHOCHER BERTHOLD·Filed 2007·Application pending·0 cites
- 1439US2010323012A1Pharmaceutical Compositions Comprising NEP-Inhibitors, Inhibitors of the Endogenous Endothelin Producing System and DiureticsSOLVAY PHARM GMBH·Filed 2010·Application pending·0 cites
- 1539US2010203132A1Pharmaceutical Compositions Comprising NEP-Inhibitors, Inhibitors of the Endogenous Endothelin Producing System and AT1 Receptor AntagonistsSOLVAY PHARM GMBH·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →